Ascidian Therapeutics

North America Legal Chronicle. November 11, 2022

ATP’s Launch of Ascidian Therapeutics

By Martina Bellini

Wilson Sonsini Goodrich & Rosati advised Ascidian Therapeutics on the deal. Life sciences venture capital firm ATP announced the launch of new biotechnology company Ascidian Therapeutics....

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

SmartBiz’s Acquisition of United Community Bancshares and Centrust Bank

Paratek Pharmaceuticals’ Acquisition of Optinose

William Chisholm-Led Investor Group’s Acquisition of Boston Celtics

Empresas Carozzi’s Bonds Offering

‘Mercado Crédito XXXIV’ Financial Trusts’ US$74.8 Million Issuance

YPF’s US$199 Million Negotiable Obligations Issuance

Podero’s €5.5 Million Seed Financing Round

Sprints and Styria Media Group’s Partnership with willhaben

Saarni Cloud’s Investment Round

Hyde Park Developments’ EGP2.6 Billion Medium-Term Financing

SolarAfrica Energy’s Financing of 114 MW SunCentral 1 PV Plant and Main Transmission Substation

Beltone’s Acquisition of SODIC For Securitization

Impact46’s $244 Million Sale of Shares in Rasan Information Technology

Benefit Systems’ Acquisition of Mars Spor Kulübü

Tabreed’s US$1.5 Billion Trust Certificate Issuance Programme and US$700 Million Green Certificates Issuance

Haitong Securities’ CNY150 Billion Merger with Guotai Junan Securities

Whitefield Income Limited’s AUD200 Million Initial Public Offering

Yamaha Motor’s Acquisition of Robotics Plus

Nelson Wilians Advogados advises on structuring innovative CRI with tokenization potential

Cleary Gottlieb Acquires Springbok AI

Supreme Court of El Salvador Blocks Enforcement of Arbitration Order in Continental Towers Dispute

Morrison Foerster Adds Team of Experienced ECVC Partners Jason Sanderson and Zainab Abdullah

Frost Brown Todd Strengthens its Public Finance Group with Addition of Rahat Huq

Morrison Foerster Adds Global Antitrust and Competition Depth in Brussels with Arrival of Jan Lang

ATP’s Launch of Ascidian Therapeutics

Standard 1 Year Membership Required